NewsBenzingaTirzepatide or Semaglutide? Novo Nordisk Says Higher Semaglutide Dose Shows Cardiovascular Edge Over Eli Lilly's Tirzepatide (CORRECTED) Tirzepatide or Semaglutide? Novo Nordisk Says Higher Semaglutide Dose Shows Cardiovascular Edge Over Eli Lilly's Tirzepatide (CORRECTED) Benzinga 2026.09.30 14:29 (GMT+0) Open on Benzinga Other news Barclays Maintains Overweight on Crown Castle, Raises Price Target to $86 Barclays Maintains Overweight on American Tower, Raises Price Target to $199 Truist Securities Maintains Hold on Expedia Group, Lowers Price Target to $288 Wells Fargo Maintains Equal-Weight on Chesapeake Utilities, Raises Price Target to $136 Capricor Therapeutics Stock Surges: What's Going On? Wells Fargo Maintains Overweight on Woodward, Lowers Price Target to $430
